Australia is welcome innovative treatment for excess weight: Retatrutide. This new dual molecule – targeting on both GLP-1 and GIP receptors – demonstrates promising outcomes in global studies, suggesting meaningful drops in body fat. While regulatory clearance is pending with the Therapeutic Goo